Answers are grounded in this paper and cite their sources.
, tedizolid combined with imipenem displayed a moderate synergistic effect (fractional inhibitory concentration index, 0.41) but no bactericidal activity. Intracellularly, tedizolid 2 μg/ml (half of the MIC), corresponding to the peak serum concentration, increased the efficacy of imipenem at 8 and 32 μg/ml. Addition of avibactam and rifabutin, alone or in combination, improved the activity of the imipenem-tedizolid combination.
No takes yet. Share an insight, caveat, or question.
Run et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: